Geron Corp. buy BiotechBee
Start price
24.06.23
/
60%
€2.88
Target price
30.04.26
€4.00
Performance (%)
-27.18%
End price
03.03.24
€2.10
Summary
This prediction ended on 03.03.24 with a price of €2.10. The prediction for Geron Corp. disappointed with a performance of -27.18%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Geron Corp. | -5.174% | -5.174% | 69.825% |
iShares Core DAX® | 3.054% | 0.066% | 16.889% |
iShares Nasdaq 100 | 4.389% | -2.130% | 31.443% |
iShares Nikkei 225® | 5.386% | -0.624% | 16.546% |
iShares S&P 500 | 2.955% | -0.948% | 26.821% |
According to BiotechBee what are the pros and cons of Geron Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Geron Corp. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Geron Corp.
Buy beendet
Stopped prediction by BiotechBee for Geron Corp.
Geron Corp.
Start price
Target price
Perf. (%)
€2.10
03.03.24
03.03.24
€3.70
31.08.26
31.08.26
108.05%
11.08.24
11.08.24
Could be very worthwhile Investment >20% year
Geron Corp.
Start price
Target price
Perf. (%)
€2.50
04.01.23
04.01.23
€6.00
31.12.25
31.12.25
38.38%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year